The idea had a family origin: his grandmother, who suffered from rheumatism and had side effects from taking oxycodone, was able to sleep much more pain-free by taking cannabis orally. In pioneering work, he decided in 2016 - long before medical cannabis was legalized - to dedicate himself to the fight against the stigmatized drug. With a market share of 25 percent, Cannamedical leads the German cannabis industry. The aim is to help people with chronic illnesses, especially pain patients, by importing and processing high-quality medicinal cannabis products. The focus is on medical care and improving the quality of life through many years of experience with medicinal cannabis. In addition, the company supports the further education of doctors, health care professionals and pharmacists to deepen their understanding of medical cannabis.